Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

This study has been completed.

Study NCT00033696 Information provided by Cancer and Leukemia Group B

First Received: April 9, 2002 Last Updated: March 7, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)

Publications:

Miller AA, Wang XF, Bogart JA, Hodgson LD, Lima CM, Radford JE, Vokes EE, Green MR; Cancer and Leukemia Group B (CALGB). Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002. J Thorac Oncol. 2007 Jul;2(7):645-51.

Miller AA, Bogart JA, Watson DM, et al.: Phase II trial of paclitaxel-topotecan-etoposide (PTE) followed by consolidation chemoradiotherapy for limited stage small cell lung cancer (LS-SCLC): CALGB 30002. [Abstract] J Clin Oncol 23 (Suppl 16): A-7170, 662s, 2005.